baber/WOPTO huggingface dataset:
Patent CA-2441699-A1 (CA)
Inventor: ARNTZEN CHARLES
IPC: A01H5/00
Filed: 2002-04-12
Abstract: The present invention provides for processing methods that preserve pharmaceutical proteins expressed in plants. Herein raw plant tissue is reduced to a stable homogenate without significant loss of protein or pharmaceutical potency. The homogenate can be used directly for pharmaceutical purposes without the need to further extract, purify, or precipitate the pharmaceutical protein. The present invention further provides a method of effective immunocontraception for animal and human application. Methods are disclosed for producing transgenic plant or plant cells which express contraceptive proteins, and which can be delivered whole, in part, or after processing, to an animal to cause a contraceptive effect in the target species.
Patent CA-2443972-A1 (CA)
Title: Barrier coatings
Inventor: MAXWELL JEFFREY W
IPC: B23K35/22
Filed: 2002-03-29
Abstract: The invention relates to a method of preventing a material from adhering to a surface. In a preferred embodiment, the material comprises weld spatter and the surface is located near a welding operation. The method comprises coatin g the surface with a slurry comprising a mineral material in water. The slurry contains from 10% to 70% solids by weight and not more than 5% by weight of a material that decomposes when heated to 1000~F for one minute. The slurry is allowed to dry to form a barrier coating before the material contacts the surface.
Patent CA-2446832-A1 (CA)
Inventor: RANIERI JOHN P
IPC: A61P13/12
Filed: 2001-12-17
Abstract: L'invention concerne une méthode de traitement de lésions rénales chez un mammifère consistant à administrer audit mammifère un mélange de facteur de croissance contenant au moins deux éléments sélectionnés de la protéine-2 morphogénique de l'os (BMP-2), de la protéine-3 morphogénique de l'os (BMP-3), de la protéine-4 morphogénique de l'os (BMP-4), de la protéine-5 morphogénique de l'os (BMP-5), de la protéine-6 morphogénique (BMP-6), de la protéine-7 morphogénique de l'os (BMP-7), du facteur  beta  de croissance de transformation(TGF- beta 1), du facteur  beta  de croissance de transformation (TGF- beta 2), du facteur  beta 3 de croissance de transformation (TGF- beta 3) ou du facteur 1 de croissance du fibroblaste (FGF-1).
Patent CA-2450071-A1 (CA)
Inventor: DE NORA VITTORIO
IPC: C25C3/12
Filed: 2002-07-09
Abstract: A long-lasting metal-based oxygen-evolving anode (10) for the electrowinning of aluminium from alumina dissolved in a molten electrolyte, has a plurality of electrochemically active anode members (15,15') spaced apart and parallel to one another. Each anode member (15) can comprise a bottom part (15a) which has a substantially constant width over its height and which is extended upwardly by a tapered top part (15b for guiding a circulation of electrolyte (30) thereon. The bottom part (15a) is usually made of a metal alloy with a substantially flat oxide bottom surface (16) which is electrochemically active for the oxidation of oxygen. The metal alloy can comprise an electrically conductive inert structural metal and an active diffusable metal that during electrolysis slowly diffuses to the electrochemically active bottom surface (16) where it is oxidised for maintaining the electrochemically active bottom surface (16) and slowly dissolves into the molten electrolyte (30), in which case the bottom part (15a) forms a long-lasting supply of the active metal diffusable to the electrochemically active bottom surface (16).
Patent CA-2454381-A1 (CA)
Inventor: PRYZBY ERIC M
IPC: G07F17/32
Filed: 2003-12-29
Abstract: A gaming machine includes a processor, a memory device, and an audio speaker system. The processor randomly selects a game outcome in response to a wager amount. The memory device is coupled to the processor and stores a plurality of audio data sets for producing a plurality of different audio outputs. The processor selects one of the plurality of audio data sets in response to the processor receiving audio instructions from an external control source electronically coupled to the gaming machine. The audio speaker system broadcasts the selected audio output to a player of the gaming machine. Further, a gaming machine network comprises a plurality of gaming machines and a central controller electronically coupled to the gaming machines. The central controller sends audio instructions for controlling the audio outputs from the audio speaker system of the gaming machines. The audio instructions may include digitally formatted audio data.
Patent CA-2455689-A1 (CA)
Title: System for controlling hydrogen network
Inventor: FAIRLIE MATTHEW
IPC: C25B1/04
Filed: 2004-01-23
Abstract: An energy supply system for supplying hydrogen and electricity in an optimal manner wherein hydrogen is produced for consumers from a network of one or more distributed hydrogen supply systems connected directly to hydrogen production processes using water electrolysis which draws electrical power from one or more captive electricity sources where all resources are connected and have market access to a public electricity grid serving a variety of other electricity consumers and power generators.
Patent CA-2456821-A1 (CA)
Inventor: CHI TING-FUNG
IPC: A61K38/17
Filed: 2002-08-01
Abstract: La présente invention concerne des réactifs, des méthodes et des matériels utiles pour tester la fertilité et qui, dans de nombreux cas, permettent la détermination bien plus rapide et appropriée de l'infertilité masculine. Lesdits réactifs comprennent des protéines ZP3, ZP2, ZP1 humaines glycosylées de manière appropriée, des peptides glycosylés, des protéines hybrides telles que la protéine fluorescente verte ZP3, des complexes non covalents de protéine ZP2 associés à la protéine ZP3, une protéine hybride de ZP2-ZP3, des matières en phase solide telles que des billes d'agarose recouvertes de ligands tels que la protéine ZP3, et autre zone artificielle. L'invention concerne des méthodes qui, dans de nombreux cas convertissent un événement biologique complexe en un événement de liaison biochimique bien défini basé sur un ou plusieurs desdits réactifs. De telles méthodes sont bien plus faciles à mettre en oeuvre et à surveiller, permettant de tester de manière diagnostique l'infertilité masculine de manière plus appropriée et plus économique. D'autres modes de réalisation concernent la détection de la réaction acrosome par quantification d'une ou de plusieurs substances libérées. L'invention concerne enfin des matériels, lesquels contiennent un ou plusieurs réactifs utiles pour effectuer le test en laboratoire de diagnostic ou dans une autre installation.
Patent CA-2459551-A1 (CA)
Title: Dispositif de regulation de la temperature pour l'administration d'un medicament en aerosol
Inventor: SCHUSTER JEFFREY A
IPC: A61M11/02
Filed: 2002-09-06
Abstract: L'invention concerne un dispositif portable de régulation de la température de l'air permettant de réchauffer l'air entourant une formulation de médicament en aérosol. En réchauffant l'air d'un aérosol, on peut réduire le diamètre des particules d'aérosol produites par un dispositif de génération d'aérosol. Par ailleurs, en réchauffant l'air, on obtient un diamètre de particules d'aérosol dans la plage requise pour administrer un médicament par la voie générale quelles que soient les conditions ambiantes. Les particules de diamètre réduit peuvent être dirigées avec une plus grande précision vers différentes zones des voies respiratoires.
Patent CA-2469045-A1 (CA)
Title: Methods of therapy for non-hodgkin's lymphoma
Inventor: HURST DEBORAH
IPC: A61K38/00
Filed: 2002-12-06
Abstract: Methods for treating a human with lymphoma using a combination of interleukin- 2 and at least one anti-CD20 antibody are provided. These therapeutic agents are administered as two separate pharmaceutical compositions, one containing IL-2, the other containing at least one anti-CD20 antibody, according to a dosing regimen. Administering of these two therapeutic agents together potentiates the effectiveness of either agent alone, resulting in a positive therapeutic response that is improved with respect to that observed with either agent alone. The therapeutic effects of these agents can be achieved using lower dosages of IL-2, thereby lessening the toxicity of prolonged IL-2 administration and the potential for tumor escape.
Patent CA-2469203-A1 (CA)
Title: A method and composition for bonding fibres to rubbers
Inventor: RICHARDSON FRANK BARNETT
IPC: F16G5/06
Filed: 2002-12-06
Abstract: A method and composition for the bonding of fibres to rubbers, the method comprising the steps of treating the fibres with a primer, treating the fibres with a resorcinol/formalin/latex preparation and curing the rubber in intimate contact with the treated fibres, wherein the primer comprises a ring-opened, maleinised polybutadiene and a phenolic derivative comprising electron-withdrawing groups. The composition can be the primer alone or in combination with the primer alone or in combination with the resorcinol/formalin/latex preparation.
Patent CA-2470015-A1 (CA)
Title: Regeneration of calcium oxide or calcium carbonate from waste calcium sulphide
Inventor: QIU KUANRONG
IPC: C01B17/50
Filed: 2004-06-04
Abstract: An alternative process whereby the calcium sulphide formed in an IGCC system from calcium oxide and/or calcium carbonate can be safely and more or less quantitatively converted by reaction with carbon dioxide to calcium carbonate and/or calcium oxide together with sulphur dioxide. The calcium oxide and/or calcium carbonate can be reused in the IGCC system, and the sulphur dioxide can be converted to a useful product, such as sulphuric acid. One result of this process is that since the furnace ashes do not contain a significant level of calcium sulphide, they can be safely disposed of in a land fill site.
Patent CA-2470450-A1 (CA)
Inventor: PERAGE MING-JING
IPC: B01D65/08
Filed: 2004-06-09
Abstract: A system for treating wastewater containing organic compounds is provided, comprising an anaerobic bioreactor, an aerobic bioreactor disposed rearwardly of the anaerobic bioreactor, and a membrane separation reactor disposed rearwardly of the aerobic bioreactor. The system is capable of removing organic pollutants in wastewater through biological treatment process and separating solid from the liquid ones by using a membrane. By employing the system for treating wastewater containing organic pollutants, organic pollutants can be effectively eliminated and the problem of scaling and fouling on the surface of the membrane prevented, thus achieving the objectives of lowering cost and improving efficiency.
Patent CA-2472203-A1 (CA)
Title: Utilisation d'une chimere de il6r/il6 pour la regeneration des cellules nerveuses
Inventor: ZHANG PEILIN
IPC: A61K35/76
Filed: 2002-12-31
Abstract: la présente invention concerne l'utilisation d'une chimère de IL6R/IL6 pour la fabrication de médicaments intervenant dans le traitement de maladies et de troubles neurologiques.
Patent CA-2475034-A1 (CA)
Title: Cord member safety connector for window blind
Inventor: NIEN MING
IPC: E06B9/326
Filed: 2004-07-19
Abstract: A connector for connecting a cord member of a window blind includes a supporting member and a coupling member detachably coupled to the supporting member. The supporting member has a receiving space and an escape opening that is communicated with the receiving space and has a diameter smaller than that of the receiving space. The coupling member has a compressible retaining portion received in the receiving space and stopped above the escape opening, and a cord member tie portion for connection of the cord member. When the cord member is pulled by an external force over a predetermined level, the retaining portion is allowed to pass through the escape opening.
Patent CA-2476762-A1 (CA)
Title: Anthraquinone dyes
Inventor: ARQUINT ALFONS
IPC: G02B5/22
Filed: 2003-03-13
Abstract: The present invention relates to a compound of formula (I) wherein R1 and R3 are each independently of the other -NHR5, NHSO2R5, -NHCOR5, -0R6 or -SR7, R2 and R4 are each independently of the other -OR6 or -SR7, with the proviso that not all of the substituents R1 to R4 are -SR7, R5 is hydrogen, alkyl, aryl, aralkyl or a group of formula -(CnH2nX)m-H wherein X is -O-, -S-, -SO2-, -NH-, -NR8-, -CONH- or -CONR8- and R8 is alkyl or aryl, n is a number from 2 to 6 and m is a number from 1 to 10, R6 is aryl or heteroaryl and R7 is alkyl, aryl, heteroaryl or a group of formula -(CnH2nX)m-H wherein X is -O-, -S-, -SO2-, -NH-, NR8-, COHN- or -CONR8- and R8 is alkyl or aryl, to a process for the preparation thereof and to the use thereof in a method of producing mass-coloured plastics or polymeric colour particles.
Patent CA-2477807-A1 (CA)
Inventor: MORRIS DAVID D
IPC: H02G9/06
Filed: 2003-03-20
Abstract: A flexible fire resistant innerduct structure (10) is configured to contain a cable within a conduit (12). The innerduct structure (10) includes a pair of adjacent strip-shaped layers of flexible material (16, 18, 20, 22) that are joined along their longitudinal edges (25) to define a channel (14) through which the cable can extend longitudinally through the innerduct structure (10) between the layers. The adjacent layers have differing widths between their longitudinal edges (25), whereby the wider layer bulges away from the narrower layer to impart an open configuration to the channel (14). Other features of the innerduct structure (10) relate to the material of which it is formed. Such features include the structure of the material, such as a woven structure, and further include properties such as melting point, tensile strength, fire resistance, elongation, coefficient of friction, crimp resistances and compression recovery.
Patent CA-2481855-A1 (CA)
Inventor: JETTER MICHELE C
IPC: A61K31/4745
Filed: 2003-03-31
Abstract: This invention is directed towards novel alkylamide derivatives as bradykinin receptor antagonists useful for the treatment of bradykinin modulated disorders such as pain, inflammation, asthma and allergy. Furthermore, the present invention is directed to novel alkylamide derivatives as bradykinin receptor agonists useful for the treatment of bradykinin modulated disorders such as hypertension and the like.
Patent CA-2482123-A1 (CA)
Inventor: TEBO JAMES A JR
IPC: A47J31/54
Filed: 2004-09-20
Abstract: A brewing apparatus including a housing having a movable lid and a brewing area under the lid; a hot water heater connected to the housing; a water pump connected to the hot water heater; a controller coupled to the hot water heater and the pump ; and a switch connected to the housing and adapted to be actuated by a user movable member. The switch is coupled to the controller. The controller is adapted to discontinue heating by the heater when the switch is moved to a deactuated position.
Patent CA-2482434-A1 (CA)
Inventor: SAVARDA RAYMOND
IPC: H04L29/06
Filed: 2003-04-08
Abstract: Selon cette invention, un premier en-tête d'un paquet est traité pour obtenir un premier protocole. Ce premier protocole est utilisé en tant que clé pour lire un enregistrement d'une structure de données dans laquelle ce premier protocole est associé à un décalage dans un second en-tête du paquet. Le second en-tête du paquet est traité en fonction du décalage dans ce second en-tête pour obtenir un second protocole. Par mise en relation de la position du champ de protocole dans le second en-tête du paquet avec un décalage stocké dans la structure de données, si les tailles et/ou les dispositions de paquet changent, l'information de décalage dans la structure de données peut être mise à jour sans qu'il ne soit nécessaire de reconcevoir et/ou reconfigurer le matériel et/ou le logiciel dans un processeur de paquets.
Patent CA-2484198-A1 (CA)
Inventor: BRITTON CHARLES JONATHAN
IPC: B29C49/06
Filed: 2003-05-06
Abstract: L'invention concerne un procédé de fabrication d'une bouteille pouvant être fermée à l'aide d'un système de fermeture par pression, un appareil permettant de fabriquer cette bouteille, une bouteille et un système de fermeture pour cette dernière. Selon le présent procédé, une bouteille (72) est fabriquée dans un ensemble à plusieurs composants. La préforme (non représentée) de la bouteille, qui est obtenue selon une technique de moulage par injection, présente des crans sur ses faces orientées vers le haut et vers l'extérieur. Cette préforme est ensuite transférée vers un moule pour soufflage, où elle est d'abord chauffée puis façonnée par l'insertion d'une canne de soufflage (62) à travers le goulot de ladite préforme, de sorte que cette dernière s'étend en son sens longitudinal. Au cours de cette opération, la face supérieure de cette préforme est recourbée, de sorte que le cran formé sur sa face orientée vers le haut s'étend alors latéralement dans le volume de la préforme. Cette préforme étirée est ensuite soufflée jusqu'à ce qu'elle prenne la forme du moule pour former ladite bouteille (72). Un système de fermeture est moulé par injection et maintenu sur cette bouteille par les crans s'étendant latéralement.
Patent CA-2484302-A1 (CA)
Title: Pile a combustible et procede de connexion d'un separateur et d'une couche electrolytique d'une pile a combustible
Inventor: SUZUKI TOSHIFUMI
IPC: H01M8/02
Filed: 2003-05-02
Abstract: Dans un ensemble de pile à combustible (1) comprenant une couche électrolytique (2) ayant un cadre (21) et un électrolyte (22) retenu dans le cadre, une paire de séparateurs (5, 6) sont connectés à la couche électrolytique au moyen d'une substance métallique (27) déposée sur un des cadres et sur chaque séparateur. Un faisceau laser est émis sur la substance métallique au moyen du cadre ou du séparateur dans un état où le cadre et chaque séparateur entrent en contact mutuel, la substance métallique formant un eutectique avec l'autre cadre et chaque séparateur.
Patent CA-2486078-A1 (CA)
Inventor: STOFFELS PAUL
IPC: A61P15/02
Filed: 2003-05-13
Abstract: The present invention concerns the microbicidal activity of certain pyrimidi ne or triazine containing non-nucleoside reverse transcriptase inhibitors. The compounds of the present invention inhibit the systemic infection of a human being with HIV, in particular, the present compounds prevent sexual HIV transmission in humans.
Patent CA-2487353-A1 (CA)
Inventor: GRIKIT MIKHAIL
IPC: A47L1/05
Filed: 2004-11-25
Abstract: A user-friendly ice scraper is provided to scrape ice from windows of vehicles. The sturdy ice scraper has a rigid plastic roller with a raised roughened surface. The roller is vibrated by an electric motor fastened to a forked extension of the handle. Advantageously the ice scraper has a high strength handle and roller. The elongated handle includes a power cable to connect to the vehicle's power system.
Patent CA-2487426-A1 (CA)
Inventor: CAROSELLI ROBERT
IPC: C07B61/00
Filed: 2003-06-03
Abstract: La présente invention se rapporte à un procédé de préparation de composés à base d'halogénure métallique de mésoporphyrine. Ledit composé d'halogénure métallique de mésoporphyrine peut être obtenu par le biais de la formation d'un nouveau composé intermédiaire de mésoporphyrine IX puis de la conversion de cet intermédiaire de mésoporphyrine IX en un halogénure métallique de mésoporphyrine par insertion d'un métal. Le nouveau composé intermédiaire peut être obtenu par hydrogénation catalytique d'une hémine dans de l'acide et extraction ultérieure.
Patent CA-2489216-A1 (CA)
Inventor: MULLIN PAUL STEVEN
IPC: H02K29/08
Filed: 2004-12-07
Abstract: An electric machine having a stator assembly that includes a stator core and a coil supported by the stator core and a rotor assembly that includes a shaft and a rotor supported by the shaft that is in magnetic interaction with the stator core. The electric machine may include a single sensor configured to detect magnetic polarities of the rotor as the rotor rotates relative to the sensor and to generate a signal representing the detected magnetic polarities of the rotor. The signal and an inverted version of the signal are utilized to control current through the coil. The current may be controlled indirectly by controlling the application of voltage to the coil. The sensor may be encapsulated on a circuit board to positively position the sensor relative to the circuit board. The circuit board may be mounted to a bearing housing of the electric machine. The sensor may be received in a pocket of a bearing housing of the electric machine so the sensor is positively positioned relative to the rotor. The rotor may be connected to the shaft with an encapsulation material.  The rotor may be formed as a single cylinder of ferrite. A tapered air gap may be formed between a portion of the stator core and a corresponding portion of the rotor. The electric machine may be a C-frame electric motor with the I-bar portion formed of grain-oriented electric steel.
Patent CA-2489681-A1 (CA)
Title: Aryl boronic acids for treating obesity
Inventor: HUVAL CHAD CORI
IPC: C07F5/02
Filed: 2002-07-01
Abstract: Disclosed is a phenyl boronic acid compound represented by Structural Formul a (I): Ar is a substituted or unsubstituted aryl group. Z and Z' are independently -O-. -NH- or -S-. X is an electron withdrawing group. R is a substituted or unsubstituted straight chained hydrocarbyl group optionally comprising one or more amine, ammonium, ether, thioether or phenylene linkin g groups and Y is -H, an amine, -[NH-(NH2)q]-NH2, halogen, -CF3, thiol, ammonium, alcohol, -COOH, -SO3H, -OSO3H or phosphonium group covalently bond ed to the terminal position of R. Each -NH- in -[NH-)CH2)q]r-NH2 is optionally N- alkylated or N,N-dialkylated and -NH2 in -[NH-(CH2)q]r-NH2 is optionally N- alkylated, N,N-dialkylated or N,N,N-triakylated. q is an integer from 2 to about 10 and r is an integer from 1 to about 5. R1 and R1' are independently - H, an aliphatic group, a substituted aliphatic group, an aryl group or a substituted aryl group, or, taken together, are a C2-C5 substituted or unsubstituted alkylene group optionally comprising an amine linking group [- N+(R1a)-]. Each R1, is Structural Formula (I) is preferably -H. R1a is-H, alkyl, substituted alkyl, phenyl or substituted phenyl. Also disclosed is a method of treating obesity in a subject by administering an effective amount of a compound represented by Structural Formula (I) and a pharmaceutical composition comprising the compound and a pharmaceutically acceptable carier or diluent.